Virtus Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $698K

  • Investors
  • 4

Virtus Therapeutics General Information

Description

Developer of small-molecule activators designed to treat rare genetic disorders like pantothenate kinase-associated neurodegeneration (PKAN). The company specializes in developing novel therapies for rare metabolic diseases, focusing on PKAN and propionic acidemia, utilizing techniques such as genomics, proteomics, and metabolomics, enabling healthcare providers to provide targeted treatment and improving patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 100 York Street
  • Apartment 4P
  • New Haven, CT 06511-5652
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 100 York Street
  • Apartment 4P
  • New Haven, CT 06511-5652
  • United States

Virtus Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Virtus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 03-Oct-2023 $698K Completed Startup
4. Accelerator/Incubator 01-Jan-2023 Completed Startup
3. Accelerator/Incubator 01-Jan-2021 Completed Startup
2. Accelerator/Incubator 01-Jan-2017 $768K $768K Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Virtus Therapeutics’s complete valuation and funding history, request access »

Virtus Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Health and Human Services Government
Accelerator for Biosciences in Connecticut Accelerator/Incubator
Yale University University
Yale Ventures Accelerator/Incubator Minority
To view Virtus Therapeutics’s complete investors history, request access »

Virtus Therapeutics FAQs

  • Where is Virtus Therapeutics headquartered?

    Virtus Therapeutics is headquartered in New Haven, CT.

  • What industry is Virtus Therapeutics in?

    Virtus Therapeutics’s primary industry is Drug Discovery.

  • Is Virtus Therapeutics a private or public company?

    Virtus Therapeutics is a Private company.

  • What is Virtus Therapeutics’s current revenue?

    The current revenue for Virtus Therapeutics is .

  • How much funding has Virtus Therapeutics raised over time?

    Virtus Therapeutics has raised $1.07M.

  • Who are Virtus Therapeutics’s investors?

    U.S. Department of Health and Human Services, Accelerator for Biosciences in Connecticut, Yale University, and Yale Ventures have invested in Virtus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process